Effect of capsazepine on cytosolic Ca2+ levels and proliferation of human prostate cancer cells

Toxicology in Vitro

Volumn 20, Issue 5, 2006, Pages 567-574

  Huang, Jong Khing ^a   Cheng, He Hsiung ^b   Huang, Chun Jen ^c,d   Kuo, Chun Chi ^e   Chen, Wei Chuan ^f   Liu, Shiuh Inn ^a   Hsu, Shu Shong ^a   Chang, Hong Tai ^a   Lu, Yih Chau ^a   Tseng, Li Ling ^a   Chiang, An Jen ^a   Chou, Chiang Ting ^a   Jan, Chung Ren ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TIAN SHENG MEMORIAL HOSPITAL   (Taiwan)

^e TZU HUI INSTITUTE OF TECHNOLOGY   (Taiwan)

^f PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Ca2+; Capsazepine; Fura 2; PC3; Prostate

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CALCIUM ION; CAPSAZEPINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FURA 2; HISTAMINE; HYDROLASE INHIBITOR; INOSITOL 1,4,5 TRISPHOSPHATE; LANTHANUM; LYSOPHOSPHOLIPASE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; TETRAZOLIUM; THAPSIGARGIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CANCER CELL; CELL PROLIFERATION; CHELATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; ENDOPLASMIC RETICULUM; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; PROSTATE CANCER;

CALCIUM; CAPSAICIN; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; EGTAZIC ACID; HUMANS; MALE; PHOSPHOLIPASE C; PROSTATIC NEOPLASMS; TRPV CATION CHANNELS;

EID: 33744552611     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2005.09.014     Document Type: Article

References (27)

1. Akerman S., Kaube H., and Goadsby P.J. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. British Journal of Pharmacology 140 4 (2003) 718-724
2. Annunziato L., Amoroso S., Pannaccione A., Cataldi M., Pignataro G., D'Alessio A., Sirabella R., Secondo A., Sibaud L., and Di Renzo G.F. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicology Letters 139 (2003) 125-133
3. Behrendt H.J., Germann T., Gillen C., Hatt H., and Jostock R. Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. British Journal of Pharmacology 141 4 (2004) 737-745
4. Bootman M.D., Berridge M.J., and Lipp P. Cooking with calcium: the recipes for composing global signals from elementary events. Cell 91 (1993) 367-373
5. Docherty R.J., Yeats J.C., and Piper A.S. Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture. British Journal of Pharmacology 121 7 (1997) 1461-1467
6. Gill C.H., Randall A., Bates S.A., Hill K., Owen D., Larkman P.M., Cairns W., Yusaf S.P., Murdock P.R., Strijbos P.J., Powell A.J., Benham C.D., and Davies C.H. Characterization of the human HCN1 channel and its inhibition by capsazepine. British Journal of Pharmacology 143 3 (2004) 411-421
7. 2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry 260 (1985) 3440-3450
8. 2+ in PC3 human prostate cancer cells. Prostate 47 3 (2001) 141-148
9. 2+ handling in human prostate cancer cells. Life Sciences 70 11 (2002) 1337-1345
10. 2+ movement in human prostate cancer cells. Life Sciences 70 26 (2002) 3167-3178
11. Kofalvi A., Vizi E.S., Ledent C., and Sperlagh B. Cannabinoids inhibit the release of [3H] glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. European Journal of Neurosciences 18 7 (2003) 1973-1978
12. Lao L.J., Song B., and Marvizon J.C. Neurokinin release produced by capsaicin acting on the central terminals and axons of primary afferents: relationship with n-methyl-d-aspartate and gaba(b) receptors. Neuroscience 121 3 (2003) 667-680
13. 2+ movement in PC3 human prostate cancer cells. Pharmacological Research 44 6 (2001) 547-552
14. Liu L., and Simon S.A. Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia. Neuroscience Letters 228 1 (1997) 29-32
15. McEleny K., Coffey R., Morrissey C., Williamson K., Zangemeister-Wittke U., Fitzpatrick J.M., and Watson R.W. An antisense oligonucleotide to cIAP-1 sensitizes prostate cancer cells to fas and TNFalpha mediated apoptosis. Prostate 59 4 (2004) 419-425
16. Oh G.S., Pae H.O., Seo W.G., Kim N.Y., Pyun K.H., Kim I.K., Shin M., and Chung H.T. Capsazepine, a vanilloid receptor antagonist, inhibits the expression of inducible nitric oxide synthase gene in lipopolysaccharide-stimulated RAW264.7 macrophages through the inactivation of nuclear transcription factor-kappa B. International Immunopharmacology 1 4 (2001) 777-784
17. Putney Jr. J.W. A model for receptor-regulated calcium entry. Cell Calcium 7 (1986) 1-12
18. Ray A.M., Benham C.D., Roberts J.C., Gill C.H., Lanneau C., Gitterman D.P., Harries M., Davis J.B., and Davies C.H. Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h). Journal of Neurosciences 23 31 (2003) 10146-10153
19. Sanchez M.G., Sanchez A.M., Collado B., Malagarie-Cazenave S., Olea N., Carmena M.J., Prieto J.C., and Diaz-Laviada I.I. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. European Journal of Pharmacology 515 1-3 (2005) 20-27
20. 2+ in human osteosarcoma cells, questioning its selectivity as a vanilloid receptor antagonist. Life Sciences 75 21 (2004) 2515-2526
21. 2+-ATPase. Proceedings of National Academy of Sciences of USA 87 (1990) 2466-2470
22. Thompson A.K., Mostafapour S.P., Denlinger L.C., Bleasdale J.E., and Fisher S.K. The aminosteroid U73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. Journal of Biological Chemistry 266 (1991) 23856-23862
23. Valenzano K.J., and Sun Q. Current perspectives on the therapeutic utility of VR1 antagonists. Current Medical Chemistry 11 24 (2004) 3185-3202
24. Veronesi B., Wei G., Zeng J.Q., and Oortgiesen M. Electrostatic charge activates inflammatory vanilloid (VR1) receptors. Neurotoxicology 24 3 (2003) 463-473
25. Walpole C.S., Bevan S., Bovermann G., Boelsterli J.J., Breckenridge R., Davies J.W., Hughes G.A., James I., Oberer L., and Winter J. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. Journal of Medical Chemistry 37 13 (1994) 1942-1954
26. Yamamura H., Ugawa S., Ueda T., Nagao M., and Shimada S. Capsazepine is a novel activator of the delta subunit of the human epithelial Na+ channel. Journal of Biological Chemistry 279 43 (2004) 44483-44489
27. 2+ channel required for the survival of prostate cancer cells. Cancer Research 64 22 (2004) 8365-8373